INSP - Inspire Medical Systems, Inc.

NYSE - NYSE Delayed Price. Currency in USD
53.60
+2.70 (+5.30%)
At close: 4:04PM EST

53.60 0.00 (0.00%)
After hours: 4:51PM EST

Stock chart is not supported by your current browser
Previous Close50.90
Open50.70
Bid51.35 x 800
Ask53.76 x 800
Day's Range50.63 - 55.13
52 Week Range22.50 - 57.87
Volume711,320
Avg. Volume270,532
Market Cap1.248B
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-2.26
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est49.14
Trade prices are not sourced from all markets
  • GlobeNewswireyesterday

    Inspire Medical Systems, Inc. Announces a Positive Coverage Policy Issued by Horizon Blue Cross Blue Shield of New Jersey

    Inspire Medical Systems, Inc. (INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea (“OSA”), announced today that Horizon Blue Cross Blue Shield of New Jersey (“Horizon BCBSNJ”) has issued a positive coverage policy of Inspire therapy. This is the second coverage policy issued by a Blue Cross Blue Shield Association (“BCBSA”) healthcare plan following BCBSA Evidence Street’s January 7, 2019 report, which stated that there is sufficient evidence to determine that Inspire therapy results in a meaningful improvement in net health outcomes for patients meeting specified criteria.

  • GlobeNewswire3 days ago

    Inspire Medical Systems, Inc. Announces First BCBS Coverage Policy following Evidence Street’s Positive Therapy Indication Summary

    Inspire Medical Systems, Inc. (INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea (“OSA”), announced today that Blue Cross of Idaho has issued a positive coverage policy of Inspire therapy.  This is the first coverage policy issued following BCBS Evidence Street’s January 7, 2019 report, which stated there is sufficient evidence to determine that Inspire therapy results in a meaningful improvement in net health outcomes for patients meeting specified criteria. Blue Cross of Idaho, the state of Idaho’s leading health insurer, is a not-for-profit mutual insurance company covering approximately 500,000 members.  Blue Cross of Idaho is an independent licensee of the Blue Cross and Blue Shield Association (BCBSA).

  • GlobeNewswire10 days ago

    Inspire Medical Systems, Inc. Announces Issuance of Positive Assessment for Inspire Therapy by Blue Cross Blue Shield Association’s Evidence Street

    Inspire Medical Systems, Inc. (INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea (“OSA”), announced today that the Blue Cross Blue Shield Association's (“BCBSA”) Evidence Street issued a positive assessment of Inspire therapy to its members. BCBSA is a national federation of 36 Blue Cross and Blue Shield (“BCBS”) companies that, when combined, is one of the leading health associations in the U.S.

  • GlobeNewswire29 days ago

    Inspire Medical Systems, Inc. to Present at the 37th Annual J.P. Morgan Healthcare Conference

    MINNEAPOLIS, Dec. 19, 2018 -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative.

  • GlobeNewswirelast month

    Inspire Medical Systems, Inc. Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares

    Inspire Medical Systems, Inc. (NYSE:  INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced today that the underwriters of its previously announced offering of 2,500,000 shares of its common stock, consisting of 1,500,000 shares offered by Inspire and 1,000,000 shares offered by certain stockholders of Inspire (the “Selling Stockholders”), have exercised in full their option to purchase an additional 375,000 shares of its common stock at a public offering price of $40.00 per share, less underwriting discounts and commissions. The exercise of the option brings the total shares of common stock sold by Inspire in the offering to 1,875,000 shares.

  • Simply Wall St.last month

    Are Inspire Medical Systems, Inc.’s (NYSE:INSP) Interest Costs Too High?

    While small-cap stocks, such as Inspire Medical Systems, Inc. (NYSE:INSP) with its market cap of US$947m, are popular for their explosive growth, investors should also be aware of their balance Read More...

  • GlobeNewswirelast month

    Inspire Medical Systems, Inc. Announces Pricing of Offering of Common Stock

    Inspire Medical Systems, Inc. (INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced today the pricing of the previously announced offering of 2,500,000 shares of its common stock, consisting of 1,500,000 shares offered by Inspire and 1,000,000 shares offered by certain stockholders of Inspire (the “Selling Stockholders”), at a public offering price of $40.00 per share, before underwriting discounts and commissions. In addition, Inspire has granted the underwriters a 30-day option to purchase up to an additional 375,000 shares of its common stock at the public offering price, less underwriting discounts and commissions.

  • GlobeNewswirelast month

    Inspire Medical Systems, Inc. Announces Proposed Offering of Common Stock

    Inspire Medical Systems, Inc. (NYSE:  INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced today the commencement of a proposed public offering of 2,500,000 shares of its common stock, consisting of 1,500,000 shares offered by Inspire and 1,000,000 shares offered by certain stockholders of Inspire (the “Selling Stockholders”). Inspire also expects to grant the underwriters a 30-day option to purchase up to an additional 375,000 shares of common stock. Inspire will not receive any proceeds from the sale of common stock offered by the Selling Stockholders.

  • GlobeNewswire2 months ago

    Inspire Medical Systems, Inc. Announces Publication of Data From ADHERE Registry

    Inspire Medical Systems, Inc. (INSP) ("Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea (OSA), announced today the publication of data from the first 508 Inspire therapy patients included in the 2,500-patient ADHERE registry.  The data demonstrated that Inspire therapy is an effective treatment option with high patient satisfaction and low adverse events.  These results represent the largest international data set for Inspire therapy generated to date. The publication, entitled “Post-Approval Upper Airway Stimulation Predictors of Treatment Efficacy in the Adhere Registry,” is available online (http://erj.ersjournals.com/content/early/2018/10/25/13993003.01405-2018) in the European Respiratory Journal, the flagship journal of the European Respiratory Society.  The lead authors of the publication are Dr. Clemens Heiser of the Technische Universität in Munich, and Dr. Maurits Boon of Thomas Jefferson University Hospital.

  • GlobeNewswire2 months ago

    Inspire Medical Systems, Inc. to Present at the 30th Annual Piper Jaffray Healthcare Conference

    MINNEAPOLIS, Nov. 14, 2018 -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative.

  • GlobeNewswire2 months ago

    Inspire Medical Systems, Inc. Announces Third Quarter 2018 Financial Results and Updates 2018 Outlook

    MINNEAPOLIS, Nov. 06, 2018 -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative.

  • GlobeNewswire3 months ago

    Inspire Medical Systems, Inc. to Present at the Stifel 2018 Healthcare Conference

    Inspire Medical Systems, Inc. (INSP) ("Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea (OSA), announced today that its management team will be presenting at the Stifel 2018 Healthcare Conference on November 13, 2018 at the Lotte New York Palace Hotel in New York. Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea.

  • Benzinga6 months ago

    Benzinga's Daily Biotech Pulse: Acceleron On Fast Lane, OncoCyte's Accurate Diagnosis, Inspire Medical Gets Aetna Coverage

    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on July 9) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ) Arrowhead Pharmaceuticals ...

  • ACCESSWIRE7 months ago

    Free Daily Technical Summary Reports on LivaNova and Three Other Medical Equipment Stocks

    WallStEquities.com monitors four Medical Appliances and Equipment stocks, namely: Globus Medical Inc. (NYSE: GMED), Inspire Medical Systems Inc. (NYSE: INSP), InspireMD Inc. (NYSE AMER: NSPR), and LivaNova PLC (NASDAQ: LIVN). Audubon, Pennsylvania headquartered Globus Medical Inc.'s shares recorded a trading volume of 636,640 shares last Friday.